Pharmacists in Green River, Wyoming


13 Pharmacists found in Green River
male pharmacist

Ajaykumar Patel


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841    

male pharmacist

Alma Killpack, PHARM D


Pharmacist
170 Commerce Dr Ste B, Green River, WY 82935
307-875-7622    

female pharmacist

Dr. Carolyn Komosinski Peavey, PHARM D


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841     307-875-0166



male pharmacist

Cory Officer


Pharmacist
1105 Bridger Dr, Green River, WY 82935
307-875-4904    

male pharmacist

Gerald Lynn Paxton, R.PH.


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841     307-875-0166

female pharmacist

Kailee Becking


Pharmacist
170 Commerce Dr Ste B, Green River, WY 82935
307-875-6722    

female pharmacist

Dr. Kristi Louise Radosevich, PHARM.D.


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841    

male pharmacist

Mark Manig, RPH


Pharmacist
2305 Maryland Dr, Green River, WY 82935
307-760-7344    

male pharmacist

Dr. Nathaniel David Gomez, PHARM D.


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841     307-875-0166

male pharmacist

Mr. Phillip Greg Reasch, RPH


Pharmacist - Pharmacotherapy
905 Bridger Dr, Green River, WY 82935
307-875-7841     307-875-0166

female pharmacist

Resha Ashly Ball


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841     307-875-0166

female pharmacist

Svetlana Wells, PHARM.D


Pharmacist
905 Bridger Dr, Green River, WY 82935
307-875-7841    

female pharmacist

Tiffanie S Toone, PHARMD


Pharmacist
135 Monroe Ave Apt E, Green River, WY 82935
801-821-1587    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.